Promising signalling pathways for the treatment of pulmonary arterial hypertension

Current Opinion in Pulmonary Medicine · Published 2026-05-04 · DOI 10.1097/mcp.0000000000001278

Authors being retrieved — see the publisher record. https://doi.org/10.1097/mcp.0000000000001278

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Robotic-assisted bronchoscopy for lung nodules and masses – can it replace CT-guided transthoracic biopsy? · Current Opinion in Pulmonary Medicine · 2026 · Same journal
• Artificial intelligence in chronic obstructive pulmonary disease: recent advances in imaging and physiological monitoring · Current Opinion in Pulmonary Medicine · 2025 · Same journal
• Update on linear endobronchial ultrasound · Current Opinion in Pulmonary Medicine · 2025 · Same journal
• Rethinking pneumonia in terms of the lung microbiome · Current Opinion in Pulmonary Medicine · 2026 · Same journal
• Diagnostic yield: what is sufficient? · Current Opinion in Pulmonary Medicine · 2025 · Same journal
• A practical framework for physicians and researchers to assess diagnostic bronchoscopy technologies in lung cancer · Current Opinion in Pulmonary Medicine · 2026 · Same journal
• Improving equity of access/transparency in organ allocation · Current Opinion in Pulmonary Medicine · 2026 · Same journal
• Update on allergen immunotherapy for asthma · Current Opinion in Pulmonary Medicine · 2026 · Same journal
• Pulmonary rehabilitation in adults with asthma · Current Opinion in Pulmonary Medicine · 2026 · Same journal
• Advanced bronchoscopy therapies for emphysema: current state and future potentials · Current Opinion in Pulmonary Medicine · 2025 · Same journal